Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
US7390832B2 · kind B2 · utility
3Cited by
2References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 12, 2002 |
| Grant date | Jun 24, 2008 |
| Priority date | — |
| Expiry date | Jan 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H21/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to a novel method for oxidizing or splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a dinuclear copper-based compound of formula I or a naked ligand of Formula II.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.